Albany, NYNCT04817618Now EnrollingIRB Ready

C3 Glomerulopathy Clinical Trial in Albany, NY

Access cutting-edge c3 glomerulopathy treatment through this clinical trial at a research site in Albany. Study-provided care at no cost to qualified participants.

Sponsored by Novartis Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Albany location

Preparing your pre-screening questions...

Expert Care in Albany

Access c3 glomerulopathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related c3 glomerulopathy treatment provided free

Apply for This Albany Location

Check if you qualify for this c3 glomerulopathy clinical trial in Albany, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Albany

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Albany site if eligible
  4. 4Begin participation

About This C3 Glomerulopathy Study in Albany

The Primary Completion Date and Study Completion Date have been updated to reflect completion of the adolescent cohort, which has been added to the protocol. The study is designed as a multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in complement 3 glomerulopathy.

Sponsor: Novartis Pharmaceuticals

Who Can Participate

Inclusion Criteria

Male and female participants age ≥ 12 and ≤ 60 years at screening.
Diagnosis of C3G as confirmed by renal biopsy within 12 months prior to enrollment in adults and within 3 years in adolescents.
Prior to randomization, all participants must have been on a maximally recommended or tolerated dose of an angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) for at least 90 days. The doses of other antiproteinuric medications including mycophenolic acid, corticosteroids and mineralocorticoid receptor antagonists should be stable for at least 90 days prior to randomization.
Reduced serum C3 (defined as less than 0.85 x lower limit of the central laboratory normal range) at Screening.
UPCR ≥ 1.0 g/g sampled from the first morning void urine sample at Day -75 and Day -15.
Estimated GFR (using the CKD-EPI formula for ages ≥ 18 years and modified Schwartz formula for ages 12 to 17 years) or measured GFR ≥ 30 ml/min/1.73m2 at screeni

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Albany?

Yes, this clinical trial (NCT04817618) has an active research site in Albany, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

C3 Glomerulopathy Treatment Options in Albany, NY

If you're searching for c3 glomerulopathy treatment options in Albany, NY, this clinical trial (NCT04817618) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Albany research site is actively enrolling participants for this clinical trial. You'll receive care from experienced c3 glomerulopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all c3 glomerulopathy clinical trials near you to find additional studies recruiting in your area.

More Myalgic Encephalomyelitis Trials in Albany, NY

See all myalgic encephalomyelitis clinical trials recruiting in Albany — not just this study.

Browse Myalgic Encephalomyelitis Trials in Albany →

Browse More Trials by Condition

Myalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Albany?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Albany, NY